University of Kentucky

UKnowledge
Markey Cancer Center Faculty Publications

Markey Cancer Center

3-15-2018

Evaluating Disparities in the U.S. Technology Transfer Ecosystem
to Improve Bench to Business Translation
James Weis
Massachusetts Institute of Technology

Ashvin Bashyam
Massachusetts Institute of Technology

Gregory J. Ekchian
Massachusetts Institute of Technology

Kathryn Paisner
KP2 LLC

Nathan L. Vanderford
University of Kentucky, nathan.vanderford@uky.edu

Follow this and additional works at: https://uknowledge.uky.edu/markey_facpub
Part of the Policy Design, Analysis, and Evaluation Commons, Science and Technology Studies
Commons, and the Translational Medical Research Commons

Right click to open a feedback form in a new tab to let us know how this document benefits you.
Repository Citation
Weis, James; Bashyam, Ashvin; Ekchian, Gregory J.; Paisner, Kathryn; and Vanderford, Nathan L.,
"Evaluating Disparities in the U.S. Technology Transfer Ecosystem to Improve Bench to Business
Translation" (2018). Markey Cancer Center Faculty Publications. 113.
https://uknowledge.uky.edu/markey_facpub/113

This Article is brought to you for free and open access by the Markey Cancer Center at UKnowledge. It has been
accepted for inclusion in Markey Cancer Center Faculty Publications by an authorized administrator of
UKnowledge. For more information, please contact UKnowledge@lsv.uky.edu.

Evaluating Disparities in the U.S. Technology Transfer Ecosystem to Improve
Bench to Business Translation
Digital Object Identifier (DOI)
https://doi.org/10.12688/f1000research.14210.1

Notes/Citation Information
Published in F1000Research, v. 7, 329, p. 1-18.
© 2018 Weis J et al.
This is an open access article distributed under the terms of the Creative Commons Attribution Licence,
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is
properly cited.

This article is available at UKnowledge: https://uknowledge.uky.edu/markey_facpub/113

F1000Research 2018, 7:329 Last updated: 08 MAY 2018

RESEARCH ARTICLE

Evaluating disparities in the U.S. technology transfer ecosystem
to improve bench to business translation [version 1; referees: 3
approved, 1 approved with reservations]
James Weis

1-4*, Ashvin Bashyam1,2,5*, Gregory J. Ekchian1,5,6*, Kathryn Paisner7,

Nathan L. Vanderford

8,9

1MIT Biotechnology Group, Massachusetts Institute of Technology, Cambridge, MA, USA
2Department of Electrical Engineering & Computer Science , Massachusetts Institute of Technology, Cambridge, MA, USA
3Computational & Systems Biology Initiative, Massachusetts Institute of Technology, Cambridge, MA, USA
4Computer Science & Artificial Intelligence Laboratory, Massachusetts Institute of Technology, Cambridge, MA, USA
5Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, USA
6Department of Materials Science & Engineering, Massachusetts Institute of Technology, Cambridge, MA, USA
7KP2 LLC, Oakland, CA, USA
8Markey Cancer Center, University of Kentucky, Lexington, KY, USA
9Department of Toxicology and Cancer Biology, College of Medicine, University of Kentucky, Lexington, KY, USA
* Equal contributors

v1

First published: 15 Mar 2018, 7:329 (doi: 10.12688/f1000research.14210.1)

Open Peer Review

Latest published: 15 Mar 2018, 7:329 (doi: 10.12688/f1000research.14210.1)

Abstract
Background: A large number of highly impactful technologies originated from
academic research, and the transfer of inventions from academic institutions to
private industry is a major driver of economic growth, and a catalyst for further
discovery. However, there are significant inefficiencies in academic technology
transfer. In this work, we conducted a data-driven assessment of translational
activity across United States (U.S.) institutions to better understand how
effective universities are in facilitating the transfer of new technologies into the
marketplace. From this analysis, we provide recommendations to guide
technology transfer policy making at both the university and national level.
Methods: Using data from the Association of University Technology Managers
U.S. Licensing Activity Survey, we defined a commercialization pipeline that
reflects the typical path intellectual property takes; from initial research funding
to startup formation and gross income. We use this pipeline to quantify the
performance of academic institutions at each step of the process, as well as
overall, and identify the top performing institutions via mean reciprocal rank.
The corresponding distributions were visualized and disparities quantified using
the Gini coefficient.
Results: We found significant discrepancies in commercialization activity
between institutions; a small number of institutions contribute to the vast
majority of total commercialization activity. By examining select top performing
institutions, we suggest improvements universities and technology transfer
offices could implement to emulate the environment at these high-performing
institutions.
Conclusion: Significant disparities in technology transfer performance exist in
which a select set of institutions produce a majority share of the total
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technology transfer activity. This disparity points to missed commercialization
opportunities, and thus, further investigation into the distribution of technology
transfer effectiveness across institutions and studies of policy changes that
would improve the effectiveness of the commercialization pipeline is warranted.
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Introduction
The transfer of inventions from academic institutions to private
industry is a major driver of economic growth and human
welfare. Broadcom, Google, Akamai, Yahoo, Biogen, Bose, and
Genentech represent just a handful of pioneering companies with
academic roots (Kenney, 2017). Indeed, many of today’s defining technologies originated in academic labs, including nuclear
energy and the internet (Busbin, 1995; Manyika & Roxburgh,
2011; Nelson & Byers, 2015).
Technology-driven progress demands not only the development
of new inventions, but also their dissemination throughout
society. Our national capacity to fuel growth and improve human
well-being through new technologies depends on our ability to
pass these technologies through a commercialization pipeline.
This national need for an efficient and effective technology
handoff between academia and industry motivated our analysis
of the current United States (U.S.) academic technology transfer
environment.
Leveraging data from the Association of University Technology
Managers (AUTM) U.S. Licensing Activity Survey, we characterized the performance of research organizations across
different steps of the technology transfer process. Our findings
indicate that the translational abilities of research organizations
across the U.S. vary widely, with a small minority of institutions
producing the vast majority of technological and economic
benefits. To begin addressing this gap, we surveyed initiatives
aimed at improving technology transfer and propose remedies
for observed disparities in institutional performance.

Methods
Defining the commercialization pipeline
The AUTM Licensing Survey solicits responses annually from
around 300 institutions, including universities, hospitals and
research institutions, to quantify the total technology transfer
activity at these institutions. These metrics are derived from a
set of core questions that AUTM deems essential for assessing
transfer and licensing activity. A detailed description of each
metric from the AUTM survey data is given in Supplementary
Table 1. We defined the “commercialization pipeline” (Figure 1)
by identifying a set of key questions asked in each AUTM
survey, and extracting relevant data from the 2010 to 2014
AUTM surveys. We use this commercialization pipeline to
measure and compare relative levels of technology transfer
activity at different institutions, and at different steps along the
pipeline. The distributions of each metric across every surveyed
institution are visualized as linear and log histograms, as well as
empirical cumulative distributions, in Supplementary Figure 1
and Supplementary Figure 2.

Identification of top performing institutions
We ranked each institution from the AUTM Licensing Survey
data by each step in the commercialization pipeline. Any
institution ranked in the top 10 (about the top 5%) in at least
one stage of the pipeline was included in the our list of top
performing institutions. This resulting list of 25 institutions
(approximately 12% of all surveyed institutions) was then sorted
based on mean reciprocal rank (MRR):

MRR =

1
N

1

∑R

i,

i

where N = 7 is the number of stages in the pipeline and Ri is
the ranking of the institution in step i of the pipeline. We chose
this scoring system to identify institutions with consistently
high performance across the commercialization pipeline while
avoiding heavily penalizing anomalous weak performances in just
a single metric.

Calculation of the Gini coefficient
Given value xi for institution i and xj for institution j, we calculate
G, the Gini Coefficient, such that:
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The Gini coefficient is a measure of statistical dispersion used
to assess inequality in a population. A high Gini coefficient
indicates high levels of inequality where, in this case, a few
institutions contribute a substantial amount of total translational
activity. Conversely, a low Gini coefficient indicates that each
institutions contributes an equal share.

Statistical analysis
Variance estimates (υ) for the Gini coefficient for each step were
derived via jackknife resampling (Karagiannis & Kovacevic’, 2000;
Yitzhaki, 1991):
N

υ=

N −1
2
(Gi − G )
∑
N i=1

where N is the number of observations, G is the Gini coefficient when all observations are considered, and Gi is the Gini
coefficient value when the ith observation is removed. The
confidence intervals of the log-normal fits were computed to
the 95% confidence levels using the Jacobian of the parameter

Figure 1. Commercialization pipeline. Each step in this pipeline corresponds to a metric in the AUTM survey. We use the health of the
pipeline as a proxy for the overall health of the U.S. technology transfer ecosystem.
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estimates assuming normally distributed residuals. All statistical
analysis was performed in MATLAB 2016b (Mathworks, Natick,
MA, USA).

contribute over 40% of “startups per dollar of research expenditures” and over 70% of “adjusted gross income per dollar of
research expenditures”.

Results
Inequality between institutions through pipeline
Our goal was to understand how much each institution
contributed to each step of the commercialization pipeline and
to determine any notable overall trends in U.S. technology
transfer. Histograms (Supplementary Figure 1 and Supplementary Figure 2) of contributions from each institution along the
commercialization pipeline reveal highly skewed distributions.
The distributions of each metric are generally well approximated
by a log-normal fit. Note that the x-axes is on a log scale and
therefore the significant skew in the distribution is not immediately apparent. The effectiveness of a log-normal fit decreases
towards the end of the commercialization pipeline (Startups
and Adjusted Gross Income).

Highly performing institutions
We identified the 25 top-performing institutions by sorting all
top-performing institutions by the average of their reciprocal
ranking at each step in the commercialization pipeline (Table 1).
Most organizations that perform well do so across the entire
commercialization pipeline, indicating strong and broad technology transfer abilities (e.g. University of California and
University of Texas Systems; MIT; and Stanford). On the other
hand, some organizations excel in only specific parts of the
commercialization pipeline (e.g. University of Washington
in Licenses and Options Executed; California Institute of Technology in New Patent Applications; and University of Georgia
in Licenses and Options Executed), which reveals focused, lessrobust technology transfer capabilities.

The majority of institutions contribute a small amount to
overall technology transfer regardless of how activity is measured (Figure 2 and Supplementary Figure 3). Specifically, the top
20% of institutions contribute over 60% of total commercialization activity. Importantly, this trend is robust to normalization by research expenditures, which indicate that differences
in research funding do not explain the gap in productivity
(Supplementary Figure 3). In fact, the top 10% of institutions

Dispersion analysis
We extended this analysis by calculating the Gini coefficient,
a measure of statistical dispersion that is often used to
quantify income inequality (Gini, 1912). In this analysis, a low
Gini coefficient indicates that each institution is contributing
roughly equally to U.S. technology commercialization, whereas
a high Gini coefficient indicates that a few institutions are
producing the majority of the commercialization output.

Figure 2. Contribution by top 1%, top 20% and bottom 80% of institution to each step of the commercialization pipeline. A small
number of institutions contribute to the majority of commercialization activity.
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As shown in Figure 3 and Supplementary Figure 3, high levels
of inequality exist throughout the pipeline. For context, the Gini
coefficient of patents issued in the U.S. is above 60%, while
the Gini coefficient of all U.S. household income is 48% (U.S.
Census Bureau). We believe this indicates that the majority of
U.S. research organizations have significant untapped commercialization potential, the full realization of which could lead to
new technologies and, overall, improved U.S. productivity.

Improving the pipeline
Many of the top performing institutions have invested significant
effort and resources in supporting entrepreneurs at each stage
of the commercialization pipeline. Top performing institutions
have ensured continuity in their support structure to enable the
efficient and effective translation and development of both institute-owned and student-created intellectual property. Table 2
highlights active programs at MIT and Harvard, two top performing translational institutions. Our summary of these initiatives
span university incubators, student organizations, university venture capital funds and business plan competitions (Table 2).

The overview of successful programs (Table 2) provides a blueprint for universities that would like to foster improved technology transfer and innovation. While some of these programs would
require a significant undertaking on the part of the university,
many can be achieved in a straightforward and lightweight manner
via the support of student-led activities and partnership with
government and private organizations. Examples of grassroot
student groups that have launched many new programs exist at
both MIT and Harvard. For instance, the MIT Biotech Group
group has partnered with the MIT Alumni Angels of Boston to
launch a life sciences-focused track to improve access to capital
for early-stage startups. The Harvard Biotechnology Club runs an
incubator program to develop and translate academic research.
These programs represent student-led efforts that require little to
no university expenditure or resources. For larger undertakings,
university/corporate collaborations can provide an efficient
means to achieve significant progress. A prime example of this
is JLABS @ M2D2, the medical device incubator partnership
between Johnson & Johnson and the University of Massachusetts
Lowell (McCarthy et al., 2013).

Table 1. The 25 top-performing institutions. Bar plots show the mean value over the years under consideration for each institution for each step in our
commercialization pipeline.
Institution

Research
Expenditures ($M)

Invention
Disclosures

New Patent
Applications (US)

Patents Issued (US)

Licenses and
Options Executed

Startups

University of California System

5364

1605

1117

359

261

66

University of Texas System

2508

772

357

173

155

24

Massachusetts Inst. of Technology (MIT)

1515

646

514

232

107

18

Stanford University

855

492

308

210

116

16

Johns Hopkins University

1540

417

400

72

132

10

University of Washington/Wash. Res. Foundation 1010

401

172

75

225

12

California Institute of Technology

426

389

565

149

51

10

University of Michigan

1257

363

152

106

115

11

UW-Madison/WARF

1113

378

129

153

63

6

University of Pennsylvania

886

386

196

78

107

15

Columbia University

737

356

230

86

82

15

University of Illinois, Chicago, Urbana

972

354

159

102

87

12

Massachusetts General Hospital

744

326

185

83

132

9

University of Florida

548

330

167

84

128

14

Cornell University

781

363

175

82

130

10

University of Utah

401

223

99

67

82

18

University of Georgia

307

163

56

34

157

3

Georgia Institute of Technology

741

364

228

79

72

10

Harvard University

812

377

213

66

78

9

University of Colorado

809

239

297

39

53

9

University System of Maryland

998

292

180

64

38

9

Duke University

845

212

127

47

118

6

University of Pittsburgh

755

264

89

49

124

6

University of South Florida

441

177

89

89

58

9

Johns Hopkins University Applied Physics
Laboratory

1101

219

59

18

29

3
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Figure 3. The Gini Coefficient for each stage in the commercialization pipeline, with G of 0% representing complete equality and
G of 100% represents complete inequality. Error bars represent one standard deviation of uncertainty as estimated via jackknife resampling
(Karagiannis & Kovacevic’, 2000; Yitzhaki, 1991).

Discussion
Expense, time, infrastructure, and the lack of partnerships are
among the most common barriers to research commercialization
and alleviating these bottlenecks allows more inventions to enter
the marketplace (Vanderford et al., 2013). Programs to increase
support for inventors at less well performing institutions to file
disclosures, pursue patent prosecution, and seek licensing deals
could significantly boost translational output. Sharing best
practices from the leaders in technology commercialization may
help bring more new technologies to market.

Supporting the commercialization pipeline
One salient feature of the top-performing institutions is their
broad portfolio of commercialization-focused initiatives. Individually, these projects typically target only a few steps on our
commercialization pipeline (for example, business plan competitions target the latter stages of the technology transfer process).
However, the best performing universities have a large number
of these efforts which, in aggregate, fully span the commercialization pipeline. This observation indicates a potential strategy
for improvement of those less well served technology transfer
pipelines; specifically, the cultivation of commercialization
focused initiatives, such as incubators, business plan competitions,
innovation prizes, law clinics, and student organizations. The
value of these efforts goes beyond their immediate impact. For
example, although when taken at face value, a business plan

competition may seem to serve only the winning team, its merit
truly stems from bringing together students, entrepreneurs,
investors, and the media in a constructive setting. The resources
required for such projects are small, and, given the disparity in
commercialization, potential societal benefits are vast.

Outsourcing technology transfer to a third-party
A clear barrier to effective commercialization of university
technology is the widespread lack of access to experienced,
motivated, and well-resourced technology transfer offices (TTO).
Many institutions are unable to support a comprehensive TTO,
hampering efforts to introduce new technology into industry.
The use of consultants can help alleviate some shortcomings, but
faces its own barriers to widespread adoption (AUTM Technology
Transfer Practice Manual).
Alternatively, a coalition of institutions could create a thirdparty technology licensing organization whose charter is to
serve the technology transfer needs of those institutions. Like
a sports agent, this third-party organization would use its expertise to strike technology transfer deals between institutions and
licensees, freeing universities to focus on their strengths. Funded
directly by the institutions and, in part, by licensing revenue, this
organization would have the necessary resources and freedom
to hire top-tier technology transfer professionals who can effectively interface between stakeholders in industry and in academia,
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Table 2. Current programs at MIT and Harvard, two of the top-performing institutions, that strengthen the
commercialization pipeline. The shaded regions denote which areas of the pipeline each program most directly
addresses.
Research
Expenditures

Invention
Disclosures

New Patent
Apps (U.S.)

Patents
Issued
(U.S.)

Licenses
and Option
Executed

Startups

Adjusted
Gross
Income

Harvard

Harvard Life Labs
A 15,000-square-foot shared laboratory space for high-potential life
sciences and biotech startups founded by Harvard
President’s Innovation Challenge
A Campus-wide competition supporting student ventures through
networking events, mentorship and funding
Harvard Catalyst Program
An NIH funded center fostering a translational
environment enabling collaboration and providing tools,
training and technologies to investigators
Harvard Biotechnology Club
A student organization that hosts events and provides
educational services that allow members to explore the
world of business and biotechnology
The Engine
An institute-backed venture capital fund empowering disruptive
technologies with the long-term capital, knowledge, and specialized
equipment and labs they need to thrive
$100K Entrepreneurship Competition
A student run entrepreneurship contest offering mentorship from venture
capitalists, serial entrepreneurs, corporate executives, and attorneys, media
exposure, prototyping funds, business plan feedback, and discounted
services

MIT

Sloan Healthcare Innovation Prize
A student run pitch competition supporting early-stage healthcare startups
with feedback from industry professionals, pitch workshops, and funding
Sandbox
An institute-backed seed funding for student-initiated
entrepreneurship ideas, mentoring from both within and outside of
MIT, and tailored educational experiences
Deshpande Center for Technological Innovation
Support for bringing early-stage technologies to the
marketplace in the form of breakthrough products and
new companies through grants, mentorship, industry
connections, and an annual symposium
MIT Biotechnology Group
A student organization that buildings strong, symbiotic
relationships between the MIT community, academia, and
industry and serves the MIT community by facilitating
development of knowledge, skills, networks, and
experiences to prepare members for biotechnology-related
careers
MIT Life Sciences Alumni Angels
An alumni run angel investing network that
supports MIT startups focused on the life
sciences with funding, connections, and
mentorship

while negotiating on behalf of the parent institutions. These
teams would work to creatively package and license technologies
to maximize their utility to society, as well as to assure that the
parent institutions receive a fair return on their investment.

Operating outside of the university, this organization would be
free to make decisions much more quickly than traditional TTOs.
Similarly, its employees would be incentivized to work in the best
interest of the parent institutions by ensuring the process is both
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efficient and maximizes value for all stakeholders. This outsourced
model of technology transfer speaks towards the latent need
for more efficient, properly incentivized, and more widespread
efforts to commercialize academic research and development
efforts.

Conclusion
As the U.S. economy becomes increasingly driven by
technological change, understanding and improving the commercialization pipeline is critically important. The significant
disparity in technology transfer performance is evident as the
top few institutions produce a very large share of the country’s
total technology transfer. We believe this disparity points to
missed commercialization opportunities, which we as a society
are paying for by missing out on potentially highly impactful
innovations.

Data availability
The AUTM Licensing Activity Survey data are available on the
organization’s website (https://www.autm.net/resources-surveys/
research-reports-databases/licensing-surveys/) by fee or institutional subscription/membership. As such, the raw data analyzed
for this study cannot be provided in the context of this article.
The 2010–2014 survey data used for this study was obtained as
part of an institutional membership (University of Kentucky).
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Supplementary material
Supplementary Figure 1. Histograms of each step in the commercialization pipeline shown in Figure 1. Insets show cumulative distributions, with shaded rectangles indicating the number of institutions necessary to reach 80% of total activity.
Click here to access the data.
 upplementary Figure 2. Histograms of each step in the commercialization pipeline shown in Figure 1 with a log x-axis. Note that the
S
x-axes is on a log scale and therefore the significant skew in the distribution is not immediately apparent.
Click here to access the data.
Supplementary Figure 3. Quantized and normalized distribution for each step in the commercialization pipeline. The shaded bars represent
the percentage of the total of each category owned by institutions in percentiles indicated.
Click here to access the data.
Supplementary Table 1. Pipeline descriptions.
Click here to access the data.
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Referee #1
The authors correctly point out that this is a skewed industry, with the top performing schools in any
given category contributing more than their share of returns. (Page 1)
The selection of top 10 institutions in the initial analysis and then expanding to top 25 institutions is
somewhat arbitrary. (Page 3)
This data is coming from institutions of all sizes that vary according to the research dollars as well
as the overall size of institutions. For an objective analysis the data needed to be normalized along
those lines. (Page 3)
Some of the stages described by the authors in Figure 1 are metrics that can be manipulated. For
example the number of patents applied for and issued really are not metrics of measuring
efficiency or impact of an office. Large number of patents can be applied for and granted, the real
measure of performance will be the number of patents that are licensed. (Page 3)
The approach of creating a composite metric is a good one, rather than just looking at the revenue
number. The Milken study is another one that has utilized this approach and is an objective
measure. The difference is that the Milken study normalized the data, as well as provided the
weighting of each factor. (Page 3)
In most cases the large revenue numbers can be attributed to a single large license or a
monetization activity from a university. The weighting of that single license will skew the result
enormously. Combined with the lack of data normalization, the results will not be reflective of the
true impact to technology commercialization from universities. The weighting factor for each of the
"steps" and how they overall impact the ranking is unclear. The weighting of the input metrics vs.
the output metrics cannot be the same, hence the rankings would change quite radically. That
explanation should be very clearly pointed out. (Page 4)
The majority of institutions here are based on their size and hence a normalization is needed to
avoid picking institutions by size only. Smaller schools often times are more efficient.
In looking at Table 1 their analysis shows the 1% and the top 19% percent of the institutions. There
are 300 institutions in the survey. Why did they pick 25 to rank?
In addition Table 1 shows that the top 20% account for 60% of results. Why didn't they cite the top
60 institutions. It would seem logical to look at the top 20%. (Table 1)
The sharing of best practices has existed for decades in the very collaborative technology transfer
community. The AUTM Leadership Conference is precisely that effort, along with the LES IP100
meeting. The fact is that, it is not easy to solicit inventions from faculty. It takes years if not decades
to get them on board with the idea that commercialization is a good thing. (Page 6)
These programs are ideal in nurturing an "ecosystem" for technology commercializatin. The
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to get them on board with the idea that commercialization is a good thing. (Page 6)
These programs are ideal in nurturing an "ecosystem" for technology commercializatin. The
authors are absolutely right about taking a holistic approach rather than just trying to increase
disclosures, patents, startups or revenues. (Page 6)
The whole idea of hiring consultants to fix technology transfer does not work. I have personally
been a consultant and a technology transfer professional for many years. The notion of fixing tech
transfer through consultant is not economically viable. Consultants most of the time do not have
the necessary understanding of the university structure and functions. Many aspects of technology
transfer will not have economic impact or metrics based impact, but they need to be done
nonetheless. Analogy of hiring consultant would be like replacing full time and dedicated
servicemen with mercenaries. Having said that, hiring of consultants for focused engagements is
highly recommended and successful offices do that often times in areas such as patent
prosecution, valuation, licensing comparable, or market analysis. If there are significant examples
that the authors can cite to support the replacement of technology transfer offices with consultants,
that would cause readers to consider such an approach. Short of that authors should either
reconsider adding this to the article or reframing the recommendation. (Page 6)
This model has been tried in Japan, where both TTOs and TLOs existed. The model failed
miserably. Not only is this model not economically viable, but it creates an atmosphere of trying to
create a consortium out of disparate companies like Amazon, Google, Ford and IBM. Some
consortiums on a limited scope such as a particular technology focus, e.g. IoT, with a few
institutions could work. Again, the authors should cite specific examples that clearly demonstrate
the validity of the proposed model otherwise reconsider adding this as a recommendation. (Page
6)
The picking of two institutions which are ranked according to the authors at #3 and #19 does seem
highly biased analysis. Additionally, the programs that the authors have described are student and
faculty programs. Technology transfer performed by universities across the board and the data
reported by AUTM do not take into account any student programs. Hence, the impact that authors
have contemplated at each stage are possibly not accurate. Suggest the inclusion of universities
from different "ecosystems" as well as exclusion of student programs from the analysis. (Page 7)
From a practical standpoint this model will be at best difficult if not impossible with the interest of
the parties diverging because of a simple reason, royalty stacking. Each inventor or assignee
wants to have the highest value for their portion of the invention. That is just one factor from an
economic standpoint. There are many other intangible factors that would be barriers. Anyone who
has setup consortia can attest to these challenges. (Page 7)
Overall, the article has significant challenges:
1. Authors are predominantly from the Boston area and are analyzing their own institution and
another institution which is in close proximity. There are more than 300 institutions and a number of
thriving "ecosystems". This is a significant bias and in some ways looks more like a marketing
piece as opposed to an objective article. The reason the two institutions are successful could be
because of the existence of industry players, local VCs, selective admission of students at two
private colleges, and many other factors.
2. Their analysis seems to have consisted solely of sorting the AUTM data, not much analysis
(interviews, or other supporting data) about the drivers of those outcomes. Hence, they don’t show
any support for their statements about technology transfer offices being under performing.
3. The recommendations or solutions that the authors are proposing are not supported by any data
or examples and are simply anecdotal. If such models have existed and worked then analysis of
those models would be helpful.

4. As we all know the Milken study was published with different results than the authors present.
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4. As we all know the Milken study was published with different results than the authors present.
They do not reference the Milken study or explain the differences. Other articles which have
attempted to perform similar analysis have cited the Milken study. (e.g. Mature Biotech
Entrepreneur in 2014)
5. Technology transfer is indeed a complex interplay of a various factors that are not always easy
to understand. The intangible factors such as location, concentration of research areas, public
versus private institution, can all have impact that cause significant disparity in the results. Authors
need to consider analyzing or at least mentioning some of those factors in this article. (Page 8 Conclusion)
Referee #2
1. The years 2010-2014 is a small, five-year sample of data, from which broader trends and
conclusions are difficult to draw. The industry moves and changes rapidly, so the 2014 data (which
is FY2014, or July 2013 – June 2014 for most institutions), is a relatively old data set.
2. Why were only the top 10 in each category of the Commercialization pipeline included in the MRR
analysis?
3. The parameters identified in the Commercialization pipeline (Figure 1) to measure the health of a
tech transfer office are, in many instances, inadequate or irrelevant. If one is trying to measure the
health of a university (not simply its TTO), then one might use research expenditures as a
reasonable variable. However, this reviewer fails to see the direct correlation between an
institution’s research expenditures and health of the TTO. Furthermore, technology
commercialization is a non-linear, dynamic process. The notion that commercialization proceeds
from left-to-right (i.e. research expenditure-invention-patent-license-startup-revenue) is
incomplete.
4. Similarly, with respect to patent applications and patents issued, such numbers depend heavily on
an individual institution’s IP strategy. For example, California Institute of Technology, files
provisional patent applications on nearly every invention disclosure that is received. How does
such a policy speak to the health of the TTO?
5. Licenses and options are certainly one reasonable metric that can be used to assess the health of
a TTO. However, all licenses and options are not created equal. Some universities will license 30
technologies or patents in a single license, and some will license the same 30 technologies or
patents in 30 different licenses. Is the second university healthier than the first? The authors have
failed to address or account for differences in quality of licenses and options between
universities. The quantities by themselves don’t paint an accurate picture.
6. For the Startups metric, the authors should address, again, the quality of the startups coming out of
the universities. Some universities create large numbers of startups in a given year, but some of
those may not be legitimate, growth-oriented startups with qualified management.
7. Adjusted Gross Income should not be used as a metric to measure the health of TTOs. The TTO
has no control over this value.
8. In the Results section on page 4, I find it disappointing that the authors go through so much
analysis to demonstrate the truth of the Pareto principle in technology transfer. The fact that 20% of
the universities contribute to 60% of “total commercialization activity” is entirely unsurprising.
9. Again, in the Results section on page 4, “Highly performing institutions”, I don’t see that the data
were normalized for research expenditures. If so, the analysis needs to be rerun. Furthermore, the
authors need to remove the University of California, University of Texas, and University of
Maryland systems because those systems report to AUTM statewide. Alternatively, the authors
could retrieve any desired data from the individual institutions in those states.

10. I am not clear on the analogy between the Gini coefficient of patents and US household
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10. I am not clear on the analogy between the Gini coefficient of patents and US household
income. How do the authors conclude that a 60% Gini coefficient for patents means that
universities have significant untapped commercialization potential?
11. Page 5, “Improving the pipeline”, along with Table 2, reads more like an advertisement for Harvard
and MIT, particularly the Biotechnology Clubs of which some of the authors are members. The
paper would be strengthened if they identified activities conducted outside of Boston-based
universities that are contributing unexpected positive results to the tech transfer ecosystem.
Discussion section comments
1. Sharing best practices across institutions is a common and frequent activity in the university tech
transfer community. Organizations like AUTM exist for such a reason.
2. Where do the authors propose universities obtain resources to promote additional
commercialization activity?
3. Do the authors have any data to support one of their proposed solutions, the outsourcing of
technology transfer to consultants?
Overall questions and comments
1. Specifically, outside of Harvard and MIT, what are institutions in the top 25 doing that other
institutions can replicate to improve their TTOs?
2. Are the authors aware of similar programs at other universities as those highlighted in Table 2?
3. Have the authors considered non-traditional factors that may contribute to the success of TTOs,
such as overall university mission, geographic location, appetite for risk, patience for technology
development timelines, etc.?
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doi:10.5256/f1000research.15458.r32093
Evan Facher
Innovation Institute, University of Pittsburgh, Pittsburgh, PA, USA
The authors tackle a very relevant question virtually all technology commercialization organizations at
academic institutes have – what can they do to enhance translation of innovations developed at their
organizations. In order to assess the current situation and provide some thoughts on approaches to
ameliorate the challenges their colleague institutes have, the authors took a well reasoned, data intensive
approach to examine a large set of information. The AUTM data is a valuable source of self-reported
figures and a large amount of it was assessed to reach the presented conclusions. The design was
appropriate and relevant to answer the hypotheses posed in this article. Further, a fairly robust statistical
analysis was performed. Given the data is available (for purchased access) to any institute of higher
learning, the analyses described in the paper can be readily replicated, and potentially expanded on, by
any group that seeks to build on it.
The conclusions drawn as a result of this assessment are supported by the data and provide multiple
areas for practioners of technology transfer to examine further for implementation. I believe the manner in
which the authors broke down the commercialization pipeline was sound and is a good model for others
to use in assessing their own processes. The only suggestion I would offer is that universities are
increasingly focusing on software licensing, as a result, not all translation will be of patented innovations
but rather copyrights. As such, there may be additional information that can be garnered for these
inventions. One additional area that may be interesting to include for the authors if they chose to
eventually expand on the analysis beyond this submission is understanding the disparity of human
resources at the AUTM schools to understand how much, if any, this specific infrastructure component is
tied to commercialization activity and AUTM metrics.
In conclusion, I enjoyed the opportunity to review this article and believe it adds to the literature on
technology transfer. A significant amount of data was used to identify recommendations that align with
opportunities most organizations can adopt.
Is the work clearly and accurately presented and does it cite the current literature?
Yes
Is the study design appropriate and is the work technically sound?
Yes
Are sufficient details of methods and analysis provided to allow replication by others?
Yes
If applicable, is the statistical analysis and its interpretation appropriate?
Yes
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Are all the source data underlying the results available to ensure full reproducibility?
Yes
Are the conclusions drawn adequately supported by the results?
Yes
Competing Interests: No competing interests were disclosed.
I have read this submission. I believe that I have an appropriate level of expertise to confirm that
it is of an acceptable scientific standard.
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Adriana Bankston
Future of Research, Abington, MA, USA
General comments:
This publication highlights an important topic in examining the effectiveness of universities to facilitate the
transfer of new technologies into the marketplace. This work also raises awareness to the fact that only a
small number of institutions contribute to the vast majority of the total commercialization activity. This is
only one of the many disparities found across U.S. institutions, and the work presented here very
effectively puts this particular disparity into a broader context.
Therefore, this type of research has the potential to be utilized as a way to press for change in the system
as a whole. Particularly for this field, a change in the system would require advocating for the
implementation of successful practices from high-performing institutions across a higher number of U.S.
institutions, so that eventually these technologies can become commonplace in all universities. To this
end, I believe it is particularly important to consider how we might provide similar types of resources to
U.S. institutions with less of an access to these tools or with fewer number of tools at their disposal as
compared to the high-performing institutions in the area of technology transfer.
The publication itself is very well-written, with the motivation for pursuing this work and its purpose being
very clearly defined. The authors have also very succinctly articulated the gap filled by this work and its
overall significance to the field, and the results support the conclusions drawn. Overall, I believe this
paper is suitable for publication in its current form. I have just a few suggestions for improvement, or ideas
that might be useful to consider if expanding or revising this paper in the future. These are mostly broad
recommendations related to whether and how the disparities described here could be reduced across
universities.
General considerations:
I would like to commend the authors for detailing the steps of the commercialization pipeline early in the
publication - this is very helpful for those who might not be very familiar with it. Similarly, the explanations
of the data analysis parameters, including the Gini coefficient, are very useful in understanding the
conclusions drawn from these studies. One suggestion I would have is to move the information from the
Supplementary Table 1 into a main table in the publication, to enable the reader to more easily and
quickly refer to these concepts in conjunction with reading Figure 1.
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I also appreciate the fact that the commercialization pipeline allows the authors to answer key questions
using relevant data in the AUTM Licensing Survey. Hower, it would be really helpful to also conduct a
more in-depth investigation of how each of the universities in the AUTM Licensing Survey measures up in
every step of the commercialization pipeline, in order to obtain a view of the national landscape on this
issue beyond just the top 25 institutions. While I realize that looking at all 300 universities may be
cumbersome and that analyzing the top 25 was a relevant strategy in this case, a more detailed analysis
might allow for looking at broader trends that exist across U.S. institutions in the technology transfer area,
which could then be utilized to guide future reforms.
In terms of the actual reforms, I would also be curious to know more about the types of policies which the
authors propose to be implemented in U.S. universities in order to improve the effectiveness of the
commercialization pipeline. As part of this question, I recognize the importance mentioning the grassroot
student groups who have launched successful programs at MIT and Harvard. Perhaps it would be helpful
to suggest how such universities can best share their strategy for success in technology transfer with
other universities in the U.S., which could potentially enable the creation of a shared collection of online
resources, and/or a network of professionals interested in helping universities improve in this area who
would meet regularly to discuss this issue.
Given that there are multiple programs described from these two institutions in Table 2, it may be helpful
to discuss more about the specifics of these programs, in terms of the similarities and differences
(perhaps in a supplementary figure) in order to point out particular elements that would be useful for other
universities to utilize and incorporate into a more universal program that could be adopted widely across
the U.S. to improve the technology transfer field. Alternatively, are there differences between these
programs that could be pointed out in order to determine their suitability for being adopted by other
universities as multiple independent programs?
I also wonder if there are other additional types of actions that could be undertaken by graduate students
and postdocs who might have an interest in this area, or by university administrators who could assist in
potentially reducing some of these disparities described here. One area that might be worth exploring in
this regard is implementing technology transfer programs in all U.S. universities (perhaps these could be
designed by a local technology transfer office) geared towards training both researchers and
administrators in this area, in order to facilitate the commercialization of the findings produced by
researchers in U.S. institutions.
I believe the idea of a third party organization, which is mentioned, could work very well. However, there
could be limitations in terms of what universities (or researchers) are willing to share with an outside
group, depending on how the agreement terms are formulated. Therefore, it may be useful to also
consider other individuals within universities who could be involved in implementing reforms in the
technology transfer process from the inside. I also wonder how to ensure that the third party organization
will associate with the institutions that are most in need of this partnership, instead of linking to the already
high performing institutions, the latter which could in fact ensure their own success. To this end, these
agreements would need to be carefully crafted with the interest of both parties in mind.
At the same time, multiple parties should contribute to the implementation of such reforms, including
those outside the university. Perhaps it would be useful to add into the current Figure 1 some suggestions
at every step along the way, indicating where improvements could be made and by whom (i.e. which
stakeholder). This broader analysis might also help with further discussions of the types of changes which
should be implemented in universities in order to ensure that all U.S. institutions have the same resources
and as the currently high-performing institutions in technology transfer, therefore aiming to reduce some
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and as the currently high-performing institutions in technology transfer, therefore aiming to reduce some
of these disparities and create a more uniform way to analyze this problem across the board. In addition,
as multiple groups are likely to be involved in this process, perhaps it would also be useful to expand this
discussion by adding in more details on the efforts already undertaken successfully by each of these
groups which could help reduced these disparities. For example this could include direct links to such
efforts, with clear instructions and concrete actions which other universities could easily adopt and
implement locally.
Specific suggestions:
Overall, the motivation for each part of the study and the actual results are very clearly explained and are
insightful. I was particularly intrigued by the findings in Table 1, and the idea that performance of
institutions in such these areas can be measured. This is encouraging to see in thinking more broadly
about the variables that can be quantified from U.S. institutions. One suggestion is that it may be useful,
after each result, or perhaps in the discussion section, to include further explanations of how each of
these findings contributes to our broader understanding of academic technology transfer. This might also
lead to an obvious list of particular weakness in the commercialization pipeline that must be corrected
across institutions.
Getting more into the data itself, with respect to Table 1, I understand the top performing institutions are
ranked as high performing in all of the presented categories. However, there are a few institutions in the
list that I would consider high performing academically, but which have been indicated to perform in a
variable manner in some of the particular areas examined within the commercialization pipeline. I am
wondering whether more discussion on these “gray area” institutions could be added, and how their
particular performance in a given area translates to benefiting the economy itself. For example, does high
performance in certain variables lead to benefits in the local economy, and is high performance in all of
these areas required to benefit the U.S. economy as a whole, or is this a more mixed population?
Along these lines, in thinking about the differences in available resources for technology transfer between
U.S. universities, I also wonder if it is possible to perform a type of analysis that would take into account
this difference and measure performance in a way that is dependent upon the available resources. For
example, a particular university may be considered successful overall for their local area given the limited
amount of resources, depending on how this analysis is performed and analyzed. However, if we only
consider universities that are high performing overall in all categories, it may be more difficult to analyze
the individual success of those institutions who only show high performance in certain areas.
Overall, I believe Table 2 contains a wealth of information that could be further analyzed and discussed to
draw additional conclusions from the data presented here, including potentially by examining the entire
dataset of 300 institutions, which could add another layer of depth and complexity to these findings.
The authors also mentioned that this analysis was performed using 2010-2014 AUTM Licensing Survey
data. As this survey data is being reported every year, it may be interesting in the future to expand beyond
this timeframe and examine more general trends in the factors presented here over a longer period of
time (for example in the last 10 years). That kind of analysis could also provide more insights into the
landscape of technology transfer as a whole, and highlight particular recommendations that could be
made (or maybe have already been made) to improve the technology transfer system in the U.S. Finally, if
available, obtaining and sharing the raw data from the Survey itself may also allow other individuals to
perform their own additional analyses of interest.
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Other than the Materials and Methods dealing with the underpinnings of the statistical methodolgy, which
are well beyond me (my failure, not the authors'), the article is clear and easy to understand. It provides an
interesting look at the University technology transfer process, and is probably of interest to a wide variety
of readers -- both those in the technology transfer field and those who care what federal research dollars
can provide.
The authors demonstrate that some universities are better than others at commercializing the research
that their professors undertake. They provide an examination of whether universities can be good at all
steps of the process; or whether it is more effective for a TTO to specialize at one, more high-leverage,
point in the process.
The article is clear, and the conclusions and findings are well-reported. The authors additionally provide a
few suggestions of how to improve or make more efficient the technology transfer process. These
takeaways will be of interest to readers in TTOs, especially.
It would be interesting for a follow-on article for the authors to examine tech transfer efforts at different
"types" of universities -- with or without a medical school; or at places where there have been blockbuster
licensing deals vs. not. But clearly those ideas are well outside the scope of this article.
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